Showing 2361-2370 of 6036 results for "".
- Artificial Iris From HumanOptics Now Reimburseable Medical Producthttps://modernod.com/news/artificial-iris-from-humanoptics-now-reimburseable-medical-product/2477301/HumanOptics AG has received health insurance approval for its artificial iris Customflex ArtificialIris in the United States. Approval by the state Centers for Medicare and Medicaid Services (CMS) as a reimbursable me
- Midwest Vision Partners Announces Partnership with Specialty Eye Institutehttps://modernod.com/news/midwest-vision-partners-announces-partnership-with-specialty-eye-institute/2477268/Midwest Vision Partners (MVP), an eye care management services organization backed by private equity firm Alpine Investors, has announced its partnership with Specialty Eye Institute (SEI). Terms
- LifeCell Receives Accreditation From American Association of Tissue Banks (AATB)https://modernod.com/news/lifecell-receives-accreditation-from-american-association-of-tissue-banks-aatb/2477240/LifeCell International, a human cells tissues and genetics services provider in India, has received accreditation from the American Association of Tissue Banks (AATB) for its birth tissue products. This accreditation positions LifeCell as the first and only compan
- EyeCarePro Acquires the Optometrists Networkhttps://modernod.com/news/eyecarepro-acquires-the-optometrists-network/2476917/As part of an overall business strategy of expanding services for optometric medical specializations, EyeCarePro acquired the assets belonging to the Optometrists Network in July 2019, according to a report in VisionMonday. These include the related networks of vision therapy and neuro-opt
- USPSTF Reaffirms Advice on Prevention of Gonococcal Eye Infections in Newbornshttps://modernod.com/news/uspstf-reaffirms-advice-on-prevention-of-gonococcal-eye-infections-in-newborns/2476334/The U.S. Preventive Services Task Force (USPSTF) continues to recommend that all newborns be treated with a topical antibiotic ointment to prevent gonococcal eye infections, according to a Reuters report. This “A” recom
- Omeros Announces Reinstatement of Pass-Through Status for Omidriahttps://modernod.com/news/omeros-announces-reinstatement-of-pass-through-status-for-omidria/2479831/Omeros announced reinstatement of separate payment by the Centers for Medicare and Medicaid Services (CMS) under the pass-through program for Omidria (phenylephrine and ketorolac intraocular solution) 1%/0.3%. The pass-through status is effective as of October 1, 2018.
- LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMDhttps://modernod.com/news/lumithera-obtains-fda-authorization-of-valeda-treatment-for-dry-amd/2482525/The FDA has granted authorization to LumiThera allowing the company to market its Valeda Light Delivery System. This approval, made under the De Novo authorization pathway, makes Valeda the first FDA-authorized device to treat vision loss in patients with dry AMD.
- Verana Health Partners with Foundation Fighting Blindness to Integrate Genetic Testing Data into Real-World Evidence Researchhttps://modernod.com/news/verana-health-partners-with-foundation-fighting-blindness-to-integrate-genetic-testing-data-into-real-world-evidence-research/2481940/Verana Health and the Foundation Fighting Blindness announced a partnership focused on providing the life sciences community with deeper and broader data to optimize and expedite clinical trials. Under the partnership, the Foundation will provide Verana with de-identified genomics
- Bausch + Lomb to Acquire Xiidra from Novartishttps://modernod.com/news/bausch-lomb-will-acquire-xiidra/2481704/Bausch + Lomb announced it has entered into a definitive agreement with Novartis under which Bausch + Lomb will acquire dry eye drug Xiidra (lifitegrast ophthalmic solution) 5%. Xiidra is a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease (DE
- Researchers Found a Way to Reactivate Dormant Cells in the Retinahttps://modernod.com/news/researchers-found-a-way-to-reactivate-dormant-cells-in-the-retina/2481610/There's new hope for potentially restoring vision in patients suffering from degenerative retinal disease, thanks to work by researchers at Université de Montréal (UdeM). Published this week in Proceedings of the National Academy of Sciences, the research was